Neoplasia/BPH

	Current and future perspectives on radioligand therapy in advanced prostate cancer. Ther Adv Med Oncol Ahmed B, Ravi P. PMID: 41536963 [PubMed]
	Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials. Eur Urol Open Sci Bickley L, Fransen van de Putte EE, van den Brink L, Marandino L, van der Mijn JC, Wilgenhof S, van Thienen JV, Haanen JBAG, Boleti E, Powles T, Zondervan PJ, Graafland NM, Tippu Z, Turajlic S, Bex A. PMID: 41536951 [PubMed]
	Stigma experiences among young and middle-aged testicular cancer survivors in China: A phenomenological study. Asia Pac J Oncol Nurs Zhao Y, Li D, Zhang M, Yan W, Shen H, Xu M, Liu Y. PMID: 41536887 [PubMed]
	Salvage stereotactic MR-Guided adaptive radiotherapy (SMART) re-irradiation for locally recurrent prostate Cancer: Clinical and dosimetric outcomes. Clin Transl Radiat Oncol Moreno-Olmedo E, Murray D, George B, Ford D, Dallas N, Das P, Sabharwal A, Nagar Y, Mills J, Perna C, Suh YE, Martin A, Camilleri P. PMID: 41536761 [PubMed]
	Perioperative Systemic Therapy in Localized Renal Cell Carcinoma: Current Evidence and Future Directions. Cureus Pereira J, Pereira-Lourenço M, Ferreira AM, Marques R, Godinho R, Peralta JP, Pereira BJ, Conceicao P, Rabaca C. PMID: 41536399 [PubMed]
	A multi-modal approach for decision making in bladder cancer. Nat Rev Urol Al-Sattar H, Ding H, Okoli O, Okoli S, Ghose A, Banna GL, Wan S, Haroon A, Wong J, Teoh J, Vasdev N, Efstathiou E, Boussios S, Adeleke S. PMID: 41535603 [PubMed - as supplied by publisher]
	The Role of Osteomimicry Factors in Prostate Cancer Progression and Metastasis. Am J Physiol Cell Physiol Elshafae S, Utzman PH, Moussa M, Fotouh A, Ponnazhagan S, Hildreth BE. PMID: 41533336 [PubMed - as supplied by publisher]
	Evaluation of hybrid DIR performance using controlling structures and points of interest in MR-guided adaptive radiotherapy for prostate cancer patients. J Appl Clin Med Phys Malkov V, Mansour IR, Kong V, Li W, Dang J, Sadeghi P, Navarro I, Padayachee J, Chung P, Winter JD, Tadic T. PMID: 41533320 [PubMed - indexed for MEDLINE]
	Sex differences in health-related quality of life after renal cell carcinoma surgery: a population-based study in Sweden. Qual Life Res Bonn SE, Westman B, Schelin MEC, Hedman C, Ljungberg B, Rosenblad AK. PMID: 41533299 [PubMed - indexed for MEDLINE]
	Beyond Sterility: the Urinary Microbiome in Bladder Cancer Carcinogenesis and Treatment. Curr Urol Rep Aron S, Meagher M, Azari S, Baker B, Nasseri R, Bagrodia A, Stewart T, Liss M, Salmasi A. PMID: 41533261 [PubMed - indexed for MEDLINE]
	Morbi-mortality of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type. J Robot Surg Deniaud C, Mesnard B, Bobet S, Perrouin-Verbe MA, Branchereau J, De Vergie S, Rigaud J. PMID: 41533243 [PubMed - indexed for MEDLINE]
	Single-cell and immune-context integration identifies basement-membrane/metastasis signatures that sharpen bladder-cancer diagnosis and prognosis. Discov Oncol Chen J, Liu X, Ren R, Yi R, Zhang X, Xie C, Liu X, Long W. PMID: 41533176 [PubMed - as supplied by publisher]
	Oncologic outcomes of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type. World J Urol Deniaud C, Mesnard B, Bobet S, Perrouin-Verbe MA, Branchereau J, De Vergie S, Rigaud J. PMID: 41533072 [PubMed - indexed for MEDLINE]
	Assessing the association between homologous recombination deficiency scores and treatment response in localized and metastatic prostate cancer. J Pathol Clin Res Zhu Q, Shi Y, Wang T, Zheng Q, Zhou X, Tan Z, Chen J, Guo J, Liu H, Shen P, Zeng H, Zhao J. PMID: 41532774 [PubMed - indexed for MEDLINE]
	Genetic relationships between the gut microbiota and prostate cancer: Mendelian randomization combined with bioinformatics analysis. Aging Male Li W, Li C, Li X, Gao Z. PMID: 41532675 [PubMed - indexed for MEDLINE]
	The Effects of Bone-Remodeling Therapy on Survival, Pain, and Skeletal Related Events in the Setting of Renal Cell Carcinoma With Bone Metastases: A Multicenter Investigation From a Large Global Health Research Network (TriNetX). Cancer Med Im BH, Zarrabi KK, Hochberg AR, Shah MS, Mark JR, Izes JK, Gomella PT, Lallas CD, Gomella LG, Metwalli AR. PMID: 41532365 [PubMed - indexed for MEDLINE]
	Predicting prostate cancer recurrence using an atlas-based tumor control probability model. Med Phys Mahtaba KR, Ebert MA, Booth J, Moghaddasi L, Finnegan R, Zhao Y, Javed B, Hruby G, Haworth A. PMID: 41532361 [PubMed - indexed for MEDLINE]
	RapidArc dynamic versus RapidArc: A multi anatomical-site dosimetric evaluation. J Appl Clin Med Phys Rostami A, Naim C, Sukumaran RP, Usman M, Mkanna AY, Al-Sabahi AF, Basith A, Chuck S, Barzegar M, Peltier BO, Aklan B, Baradaran S, Paloor SP, Hammoud RW. PMID: 41532265 [PubMed - indexed for MEDLINE]
	Translational Advances in Urothelial Carcinoma: From Bench to Bedside. Int J Urol Iwasawa T, Tsujino T, Tsukahara S, Fukushima H, Ito D, Tomiyama E, Urabe F, Japanese Young Urologist Basic Research Collaboration. PMID: 41531330 [PubMed - indexed for MEDLINE]
	Genitourinary Toxicity, Function, and Quality of Life in Patients Undergoing Prostate Radiation Therapy-A ScopingÂ Review. Low Urin Tract Symptoms Vrij C, Heesakkers J, Van Limbergen EJ, Palmgren JE, Leers M, de Jong M, Oerlemans D, Bruins HM, Marcellissen T, Rademakers K, de Vries P, Driessen EJM, van Osch F, van den Berkmortel F, van Roermund J, Hermans T. PMID: 41531161 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 184664

Page 1 of 9234



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy